Disruption of the CRC by deleting TNBC-specific SEs or downregulating VAX2 expression attenuated the malignant characteristics of this mesenchymal subtype and reduced its sensitivity to BETi. The gene discussed is VAX2; the disease is colorectal carcinoma.